APA (7th ed.) Citation

Becchetti, C., Dirchwolf, M., Berzigotti, A., & Bosch, J. (2023). Letter: PCSK9 inhibitor for liver transplant patients during the post‐statin era? Authors' reply. Alimentary Pharmacology & Therapeutics, 57(1), 187. https://doi.org/10.1111/apt.17295

Chicago Style (17th ed.) Citation

Becchetti, Chiara, Melisa Dirchwolf, Annalisa Berzigotti, and Jaume Bosch. "Letter: PCSK9 Inhibitor for Liver Transplant Patients During the Post‐statin Era? Authors' Reply." Alimentary Pharmacology & Therapeutics 57, no. 1 (2023): 187. https://doi.org/10.1111/apt.17295.

MLA (9th ed.) Citation

Becchetti, Chiara, et al. "Letter: PCSK9 Inhibitor for Liver Transplant Patients During the Post‐statin Era? Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 57, no. 1, 2023, p. 187, https://doi.org/10.1111/apt.17295.